Search Results
May 06, 2026, 09:00 ET BW Investor Alert: Babcock & Wilcox Enterprises Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Wolfpack Allegedly Exposed Contract Fraud: Levi & Korsinsky
Find out if you can recover losses from the BW stock decline or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.BW shares had traded as high as $14.76 on March 11, 2026. The
More news about: Levi & Korsinsky, LLP
May 05, 2026, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 15, 2026 in Babcock & Wilcox Enterprises, Inc. Lawsuit - BW
5, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Babcock & Wilcox Enterprises, Inc. (NYSE: BW).
More news about: The Gross Law Firm
May 03, 2026, 19:00 ET BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Babcock & Wilcox Enterprises, Inc. ("B&W") (NYSE: BW) between November 5, 2025 and March 11, 2026, inclusive (the "Class Period"), of the important June 15, 2026 lead plaintiff deadline.So what: If
More news about: The Rosen Law Firm, P.A.
Apr 30, 2026, 21:10 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
Pomerantz LLP announces that a class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE: BW) and certain officers. The class action, filed in the United States District Court for the Northern District of Ohio, and docketed under 26-cv-00886,
More news about: Pomerantz LLP
Apr 30, 2026, 09:00 ET BW Lawsuit Alleges Executives Allegedly Certified Misleading Statements - Babcock & Wilcox Enterprises Investors Face Losses Following Executives Allegedly Certified Misleading Statements: SueWallSt
consecutive years). Over 70 professionals. Hundreds of millions recovered.Frequently Asked Questions About the BW LawsuitQ: Who are the defendants named in the BW lawsuit? A: The complaint names Babcock & Wilcox Enterprises, Inc. and individual defendants including Chairman
More news about: SueWallSt.com
Apr 29, 2026, 09:00 ET BW Investor Alert: Babcock & Wilcox Enterprises Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Filed Inadequate Disclosures: Levi & Korsinsky
examines the adequacy of Babcock & Wilcox Enterprises, Inc.'s (NYSE: BW) risk disclosures surrounding a purported $2.4 billion power generation contract. A securities class action has been filed on behalf of shareholders who purchased BW securities between November 5, 2025 and March 11, 2026.
More news about: Levi & Korsinsky
Apr 28, 2026, 14:54 ET Robbins LLP Urges BW Stockholders Who Lost Money Investing in Babcock & Wilcox Enterprises to Contact the Firm for Information About Leading the Class Action
stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Babcock & Wilcox Enterprises, Inc. (NYSE: BW) securities between November 5, 2025 and March 11, 2026. Babcock & Wilcox provides energy and emissions control solutions to industrial, electrical
More news about: Robbins LLP
Apr 28, 2026, 09:00 ET BW Deadline Alert: The Gross Law Firm Reminds Babcock & Wilcox Enterprises, Inc. (BW) Investors of Securities Class Action Deadline on June 15, 2026
28, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Babcock & Wilcox Enterprises, Inc. (NYSE: BW).
More news about: The Gross Law Firm
Apr 28, 2026, 08:00 ET Argo Biopharma Announces First Subject Dosed in Phase I Study of siRNA Therapeutic BW-50218
to developing next-generation siRNA therapies, today announced the first subject has been dosed in its Phase I clinical trial evaluating BW-50218, in Australia. BW-50218 is an siRNA therapeutic agent targeting the transthyretin protein (TTR).
More news about: Argo Biopharmaceutical Co., Ltd
Apr 23, 2026, 09:06 ET CLASS ACTION NOTICE: Berger Montague Advises Babcock & Wilcox Enterprises, Inc. (NYSE: BW) Investors to Inquire About a Securities Fraud Class Action
Berger Montague PC announces a class action lawsuit against Babcock & Wilcox Enterprises, Inc. (NYSE: BW) ("B&W" or the "Company") on behalf of investors who purchased or acquired B&W shares during the period from November 5, 2025 through March
More news about: Berger Montague
Apr 23, 2026, 09:00 ET BW Lawsuit Alleges BRC Allegedly Provided Exit Liquidity - Babcock & Wilcox Enterprises Investors Face Losses Following BRC Allegedly Provided Exit Liquidity: SueWallSt
recovered hundreds of millions of dollars for investors.Frequently Asked Questions About the BW LawsuitQ: Who is eligible to join the BW investor lawsuit? A: Investors who purchased BW stock or securities between November 5, 2025 and March 11, 2026 and suffered financial losses may
More news about: SueWallSt.com
Apr 23, 2026, 02:34 ET DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS
[5] Wijaya ST, Ngoi NY, Loh JW, Tan TZ, Lim D, Khan IS, Thian YL, Lai A, Ang BW, Tong P, Ng J, Low JJ, Ilancheran A, Lim SE, Lim YW, Tan DS. Comprehensive characterization of genomic features and clinical outcomes following targeted
More news about: National University Cancer Institute, Singapore (NCIS)
Apr 22, 2026, 09:00 ET BW Investor Alert: Babcock & Wilcox Enterprises Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Violated Disclosure Regulations: Levi & Korsinsky
www.zlk.comFrequently Asked Questions About the BW LawsuitQ: What is the BW lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is June 15, 2026. This deadline applies only
More news about: Levi & Korsinsky, LLP
Apr 21, 2026, 23:47 ET Persistent meldet für das Geschäftsjahr 2026 einen Umsatz von 1.654,4 Mio. US-Dollar bei einem Wachstum von 17,4 % gegenüber dem Vorjahr und einer EBIT-Marge von 15,6 %
Persistent wurde von der BW Businessworld Group als eines der nachhaltigsten Unternehmen Indiens ausgezeichnet
More news about: Persistent Systems
Apr 21, 2026, 17:02 ET Persistent annonce un chiffre d'affaires de 1 654,4 millions de dollars pour l'exercice 2026, soit une croissance de 17,4 % par rapport à l'année précédente, et une marge EBIT de 15,6 %.
Persistent figure au palmarès des entreprises indiennes les plus durables établi par le groupe BW Businessworld
More news about: Persistent Systems
Apr 21, 2026, 11:01 ET Persistent Reports $1,654.4M FY26 Revenue with 17.4% Y-o-Y Growth and 15.6% EBIT Margin
Persistent recognized among BW Businessworld Group's India's Most Sustainable Companies
More news about: Persistent Systems
Apr 21, 2026, 10:59 ET Persistent Reports $1,654.4M FY26 Revenue with 17.4% Y-o-Y Growth and 15.6% EBIT Margin
Persistent recognized among BW Businessworld Group's India's Most Sustainable Companies
More news about: Persistent Systems
Apr 21, 2026, 09:00 ET BW Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Babcock & Wilcox Enterprises, Inc. Securities Lawsuit -- The Gross Law Firm
21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Babcock & Wilcox Enterprises, Inc. (NYSE: BW).
More news about: The Gross Law Firm
Apr 21, 2026, 04:58 ET BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit
rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Babcock & Wilcox Enterprises, Inc. ("B&W") (NYSE: BW) between November 5, 2025 and March 11, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead
More news about: THE ROSEN LAW FIRM, P. A.
Apr 20, 2026, 08:00 ET Argo Biopharma Doses First Patients in Phase II Clinical Trials of siRNA Therapy BW-40202
today announced the first patient has been dosed in multiple Phase II studies of BW-40202, an investigational siRNA therapy targeting complement factor B (CFB). Each Phase II clinical trial has been designed to evaluate BW-40202 as a potential treatment for patients suffering from complement-mediated diseases
More news about: Argo Biopharmaceutical Co., Ltd
Apr 16, 2026, 18:07 ET BW Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Babcock & Wilcox Enterprises, Inc.
stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Babcock & Wilcox Enterprises, Inc. (NYSE: BW) securities between November 5, 2025 and March 11, 2026. Babcock & Wilcox provides energy and emissions control solutions to industrial, electrical
More news about: Robbins LLP
Apr 16, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
Pomerantz LLP announces that a class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE: BW) and certain officers. The class action, filed in the United States District Court for the Northern District of Ohio, and docketed under 26-cv-00886,
More news about: Pomerantz LLP
Apr 15, 2026, 14:16 ET BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit
rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Babcock & Wilcox Enterprises, Inc. ("B&W") (NYSE: BW) between November 5, 2025 and March 11, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead
More news about: THE ROSEN LAW FIRM, P. A.
Apr 09, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Babcock & Wilcox Enterprises, Inc. - BW
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE: BW). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Apr 07, 2026, 05:01 ET Persistent Among India's Most Sustainable Companies, Signaling Discipline at Scale
Persistent Systems (BSE: 533179) (NSE: PERSISTENT), a global leader in Digital Engineering and Enterprise Modernization, has been recognized among BW Businessworld Group's India's Most Sustainable Companies (IMSC) 2024-25, ranking 3rd overall and 2nd in the Information Technology
More news about: Persistent Systems